[1]
|
Cuenza, L.R., Razon, T.L.J. and Dayrit, J.C. (2017) Correlation between Severity of Ultrasonographic Nonalcoholic Fat-ty Liver Disease and Cardiometabolic Risk among Filipino Wellness Patients. Journal of Cardiovascular and Thoracic Research, 9, 85-89. https://doi.org/10.15171/jcvtr.2017.14
|
[2]
|
Mantovani, A., Ballestri, S., Lonardo, A., et al. (2016) Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease. Digestive Diseases and Sciences, 61, 1246-1267.
https://doi.org/10.1007/s10620-016-4040-6
|
[3]
|
Bozkurt, B., Coats, A.J., Tsutsui, H., et al. (2021) Universal Def-inition and Classification of Heart Failure: A Report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure. Journal of Cardiac Failure, 23, 352-380. https://doi.org/10.1002/ejhf.2115
|
[4]
|
Pieske, B., Tschöpe, C., De Boer, R.A., et al. (2019) How to Diagnose Heart Failure with Preserved Ejection Fraction: The HFA-PEFF Diagnostic Algorithm: A Consensus Recommendation from the Heart Failure Association (HFA) of the Eu-ropean Society of Cardiology (ESC). European Heart Journal, 40, 3297-3317.
https://doi.org/10.1093/eurheartj/ehz641
|
[5]
|
Groenewegen, A., Rutten, F.H., Mosterd, A., et al. (2020) Epidemi-ology of Heart Failure. European Journal of Heart Failure, 22, 1342-1356. https://doi.org/10.1002/ejhf.1858
|
[6]
|
Ambrosy, A.P., Fonarow, G.C., Butler, J., et al. (2014) The Global Health and Economic Burden of Hospitalizations for Heart Failure: Lessons Learned from Hospitalized Heart Failure Registries. Journal of the American College of Cardiology, 63, 1123-1133. https://doi.org/10.1016/j.jacc.2013.11.053
|
[7]
|
Arora, S., Lahewala, S., Hassan Virk, H.U., et al. (2017) Etiolo-gies, Trends, and Predictors of 30-Day Readmissions in Patients with Diastolic Heart Failure. American Journal of Car-diology, 120, 616-624.
https://doi.org/10.1016/j.amjcard.2017.05.028
|
[8]
|
Chamberlain, A.M., Boyd, C.M., Manemann, S.M., et al. (2020) Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction. The American Jour-nal of Medicine, 133, e237-e248.
https://doi.org/10.1016/j.amjmed.2019.10.030
|
[9]
|
Tsao, C.W., Lyass, A., Enserro, D., et al. (2018) Temporal Trends in the Incidence of and Mortality Associated with Heart Failure with Preserved and Reduced Ejection Fraction. JACC Heart Fail, 6, 678-685.
https://doi.org/10.1016/j.jchf.2018.03.006
|
[10]
|
Cariou, B., Byrne, C.D., Loomba, R., et al. (2021) Nonalcoholic Fatty Liver Disease as a Metabolic Disease in Humans: A Literature Review. Diabetes, Obesity and Metabolism, 23, 1069-1083. https://doi.org/10.1111/dom.14322
|
[11]
|
Younossi, Z.M. (2019) Non-Alcoholic Fatty Liver Dis-ease—A Global Public Health Perspective. Journal of Hepatology, 70, 531-544. https://doi.org/10.1016/j.jhep.2018.10.033
|
[12]
|
Ge, X., Zheng, L., Wang, M., et al. (2020) Prevalence Trends in Non-Alcoholic Fatty Liver Disease at the Global, Regional and National Levels, 1990-2017: A Population-Based Obser-vational Study. BMJ Open, 10, e036663.
https://doi.org/10.1136/bmjopen-2019-036663
|
[13]
|
Zhang, X., Wu, M., Liu, Z., et al. (2021) Increasing Prevalence of NAFLD/NASH among Children, Adolescents and Young Adults from 1990 to 2017: A Population-Based Observa-tional Study. BMJ Open, 11, e042843.
https://doi.org/10.1136/bmjopen-2020-042843
|
[14]
|
Cotter, T.G. and Rinella, M. (2020) Nonalcoholic Fatty Liver Disease 2020: The State of the Disease. Gastroenterology, 158, 1851-1864. https://doi.org/10.1053/j.gastro.2020.01.052
|
[15]
|
Packer, M. (2020) Atrial Fibrillation and Heart Failure with Pre-served Ejection Fraction in Patients with Nonalcoholic Fatty Liver Disease. The American Journal of Medicine, 133, 170-177. https://doi.org/10.1016/j.amjmed.2019.09.002
|
[16]
|
Dakroub, A., Nasser, S.A., Younis, N., et al. (2020) Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders. Cells, 9, Article 2444. https://doi.org/10.3390/cells9112444
|
[17]
|
Lee, M.W., Lee, M. and Oh, K.J. (2019) Adipose Tissue-Derived Sig-natures for Obesity and Type 2 Diabetes: Adipokines, Batokines and MicroRNAs. Journal of Clinical Medicine, 8, Arti-cle 854. https://doi.org/10.3390/jcm8060854
|
[18]
|
Packer, M. (2018) Epicardial Adipose Tissue May Mediate Del-eterious Effects of Obesity and Inflammation on the Myocardium. Journal of the American College of Cardiology, 71, 2360-2372.
https://doi.org/10.1016/j.jacc.2018.03.509
|
[19]
|
Heo, Y.J., Choi, S.E., Jeon, J.Y., et al. (2019) Visfatin Induces In-flammation and Insulin Resistance via the NF-κB and STAT3 Signaling Pathways in Hepatocytes. Journal of Diabetes Research, 2019, Article ID: 4021623.
https://doi.org/10.1155/2019/4021623
|
[20]
|
Gogiraju, R., Hubert, A., Fahrer, J., et al. (2019) Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis following Pressure Overload by Suppressing Akt/mTOR Signaling. Circulation: Heart Failure, 12, e005622. https://doi.org/10.1161/CIRCHEARTFAILURE.118.005622
|
[21]
|
Itier, R., Guillaume, M., Ricci, J.E., et al. (2021) Non-Alcoholic Fatty Liver Disease and Heart Failure with Preserved Ejection Fraction: From Pathophysiology to Practi-cal Issues. ESC Heart Fail, 8, 789-798.
https://doi.org/10.1002/ehf2.13222
|
[22]
|
D’oria, R., Schipani, R., Leonardini, A., et al. (2020) The Role of Oxida-tive Stress in Cardiac Disease: From Physiological Response to Injury Factor. Oxidative Medicine and Cellular Longevi-ty, 2020, Article ID: 5732956.
https://doi.org/10.1155/2020/5732956
|
[23]
|
Leggat, J., Bidault, G. and Vidal-Puig, A. (2021) Lipotoxicity: A Driver of Heart Failure with Preserved Ejection Fraction? Clinical Science, 135, 2265-2283. https://doi.org/10.1042/CS20210127
|
[24]
|
Budde, H., Hassoun, R., Mügge, A., et al. (2022) Current Understand-ing of Molecular Pathophysiology of Heart Failure with Preserved Ejection Fraction. Frontiers in Physiology, 13, Article 928232.
https://doi.org/10.3389/fphys.2022.928232
|
[25]
|
Kumar, A.A., Kelly, D.P. and Chirinos, J.A. (2019) Mitochondrial Dysfunction in Heart Failure with Preserved Ejection Fraction. Circulation, 139, 1435-1450. https://doi.org/10.1161/CIRCULATIONAHA.118.036259
|
[26]
|
Eisner, D.A., Caldwell, J.L., Kistamas, K., et al. (2017) Calcium and Excitation-Contraction Coupling in the Heart. Circulation Research, 121, 181-195. https://doi.org/10.1161/CIRCRESAHA.117.310230
|
[27]
|
Benitah, J.P., Perrier, R., Mercadier, J.J., et al. (2021) RyR2 and Calcium Release in Heart Failure. Frontiers in Physiology, 12, Article 734210. https://doi.org/10.3389/fphys.2021.734210
|
[28]
|
Santulli, G., Xie, W., Reiken, S.R., et al. (2015) Mitochondrial Calcium Overload Is a Key Determinant in Heart Failure. Proceedings of the National Academy of Sciences of the United States of America, 112, 11389-11394.
https://doi.org/10.1073/pnas.1513047112
|
[29]
|
Chen, J. and Vitetta, L. (2020) Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications. International Journal of Molecular Sciences, 21, Article 5214. https://doi.org/10.3390/ijms21020521
|
[30]
|
Hoyles, L., Fernández-Real, J.M., Federici, M., et al. (2018) Publisher Correction: Molecular Phenomics and Metagenomics of Hepatic Steatosis in Non-Diabetic Obese Women. Nature Medi-cine, 24, Article No. 1628.
https://doi.org/10.1038/s41591-018-0169-5
|
[31]
|
Beale, A.L., O’donnell, J.A., Nakai, M.E., et al. (2021) The Gut Microbiome of Heart Failure with Preserved Ejection Fraction. Journal of the American Heart Association, 10, e020654. https://doi.org/10.1161/JAHA.120.020654
|
[32]
|
Chiu, L.S., Pedley, A., Massaro, J.M., et al. (2020) The Associa-tion of Non-Alcoholic Fatty Liver Disease and Cardiac Structure and Function-Framingham Heart Study. Liver Interna-tional, 40, 2445-2454.
https://doi.org/10.1111/liv.14600
|
[33]
|
Li, W., Wen, W., Xie, D., et al. (2022) Association between Non-Alcoholic Fatty Liver Disease and Risk of Incident Heart Failure: A Meta-Analysis of Observational Studies. Therapeutic Advances in Chronic Disease, 13, 1-11.
https://doi.org/10.1177/20406223221119626
|
[34]
|
Mantovani, A., Petracca, G., Csermely, A., et al. (2022) Non-Alcoholic Fatty Liver Disease and Risk of New-Onset Heart Failure: An Updated Meta-Analysis of about 11 Mil-lion Individuals. Gut, 72, 372-380.
https://doi.org/10.1136/gutjnl-2022-327672
|
[35]
|
Kim, N.H., Park, J., Kim, S.H., et al. (2014) Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome and Subclinical Cardiovascular Changes in the General Population. Heart, 100, 938-943. https://doi.org/10.1136/heartjnl-2013-305099
|